- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00285740
Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting
July 19, 2019 updated by: Stanford University
This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy.
The CBT groups will be tailored for an epilepsy clinic population.
There are 12 sessions of therapy in the study held once a week for 12 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Depression is frequent in PWE and often missed for unclear reasons.
Busy neurology clinics and their overworked physicians often lack psychiatric backup that may make inquiring about psychological issues problematic.
In the psychiatric community, awareness of the need for depression intervention in the primary care clinic has been recognized for many years and several treatment models exist.
This study will attempt to use one such model, i.e.
Cognitive-Behavioral Therapy (CBT) using a group format and tailoring its use for an epilepsy clinic population.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria::- Patients will be screened with the Beck Depression Inventory.
Those reaching the positive cut-off score of 11 (indicating at least a mild depression) will be entered into the study.
Patients entered on antidepressants will be held at a stable dosage.
Anti-epileptic drugs will also be maintained on the same dosage at entry into the study when possible clinically, after consultation with their neurologist.
Exclusion Criteria:- Patients will be excluded if there is any active serious medical conditions, Standard Score<70 as assessed via the Wide Range Achievement Test, psychotic or substance abuse issues, those who are unable to maintain a stable dose of medications for the duration of study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Beck Depression Inventory
|
Secondary Outcome Measures
Outcome Measure |
---|
NDDI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 1, 2005
Primary Completion (ACTUAL)
January 1, 2007
Study Completion (ACTUAL)
January 1, 2007
Study Registration Dates
First Submitted
January 31, 2006
First Submitted That Met QC Criteria
January 31, 2006
First Posted (ESTIMATE)
February 2, 2006
Study Record Updates
Last Update Posted (ACTUAL)
July 23, 2019
Last Update Submitted That Met QC Criteria
July 19, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2903
- 34121
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, Major Depressive DisorderUnited States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
Clinical Trials on Cognitive Behavioral Therapy (CBT) in a Group Format
-
Federal University of Health Science of Porto AlegreCompleted
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDepression | Traumatic Brain InjuryUnited States
-
Emory UniversityAlzheimer's AssociationCompleted
-
Yale UniversityDepartment of Health and Human Services; Office of Research on Women's Health...Completed
-
Region SkaneLund UniversityActive, not recruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedHIV Infections | Substance Use | Mental Health | Family Relations | Risky Sexual Behavior | Physical Health
-
Region of Southern DenmarkOdense University Hospital; University of Southern Denmark; Universite du Quebec... and other collaboratorsActive, not recruitingSocial Anxiety | Social PhobiaDenmark
-
Douglas Mental Health University InstituteCanadian Institutes of Health Research (CIHR)CompletedPsychosis | Social PhobiaCanada
-
University of Missouri-ColumbiaCompletedAutism Spectrum Disorder | Chronic InsomniaUnited States